Good Distribution Practice, the regulatory framework governing pharmaceutical logistics across the EU and UK, imposes a materially stricter chain of custody standard than general cold chain freight, and the gap between the two is where pharmaceutical logistics providers most often fall short – not through negligence, but through applying strong cold chain practices that were never actually built to satisfy a GDP audit. RoadFreightCompany moves pharmaceutical freight under GDP-compliant processes specifically built around the regulation’s requirements, rather than treating pharmaceutical freight as a stricter version of general cold chain logistics.
Why Pharmaceutical Freight Is Regulated Differently From Other Cold Chain Goods
GDP treats the transport leg as a regulated extension of the manufacturing and storage chain rather than a separate logistics function operating under its own standards, which means the same product integrity obligations that apply inside a licensed pharmaceutical warehouse extend directly onto the vehicle and through every handover point in transit. This framing has practical consequences that go beyond temperature control: it requires a documented, auditable chain of custody that accounts for every party who had control of the product, the specific conditions maintained at every stage, and formal qualification of every facility and carrier involved in the movement, not just the shipper’s own operations.
The Chain of Custody Requirements That Get Overlooked
The chain of custody gaps that most often surface in a GDP audit are rarely about temperature control itself, which most cold chain operators handle competently – they concern the documentation and qualification trail surrounding the temperature control. A carrier used for a single overflow shipment without having gone through the same GDP qualification process as the primary carrier network creates a gap in the audit trail that a regulator will identify immediately, even if that specific shipment’s temperature record was perfect throughout. Subcontracted final-mile delivery, common in pharmaceutical distribution to smaller pharmacies and clinics, is a particularly frequent gap, because the subcontractor is often several steps removed from the shipper’s own GDP qualification process.
The carrier qualification process RoadFreightCompany applies to every party handling pharmaceutical freight, including subcontracted final-mile providers, closes exactly this gap, because a chain of custody is only as strong as its weakest, least-scrutinised link, and that link is disproportionately likely to be a subcontractor added for capacity reasons rather than a primary, well-vetted carrier relationship.
Temperature Excursion Response Under GDP, Not Just Cold Chain Best Practice
General cold chain best practice treats a temperature excursion as an operational issue to be investigated and, where necessary, escalated to a claims process. GDP treats a temperature excursion as a potential product quality event requiring a formal, documented deviation assessment – typically involving a qualified person’s judgment on whether the affected product remains fit for use – which is a materially more rigorous and more heavily documented process than a standard cold chain incident review. Building an excursion response process that produces the specific documentation a qualified person’s assessment requires, rather than a general incident report adequate for a standard cold chain claim, is a distinct requirement that a general cold chain operation moving into pharmaceutical freight for the first time frequently underestimates.
Documentation That Holds Up to a Qualified Person’s Audit
The documentation standard GDP requires is built to withstand scrutiny from a qualified person conducting a formal audit, not simply to satisfy an internal quality check – which means records need to be complete, contemporaneous, and traceable to a specific individual and timestamp at every handover point, with no gaps that require reconstruction from memory or informal notes after the fact. Road Freight Company builds its pharmaceutical freight documentation to this audit standard from the outset, because retrofitting a documentation process to satisfy GDP after an audit has already identified gaps is a considerably more disruptive and costly process than building it correctly the first time.
GDP compliance is not simply strict cold chain practice – it is a distinct regulatory standard with its own documentation, qualification, and deviation assessment requirements that a general cold chain operation needs to build specifically, not infer from general good practice.
The gaps that surface in GDP audits are consistently concentrated in chain of custody and documentation rather than in the temperature control itself, which is exactly where a pharmaceutical logistics review should focus first.
For shippers moving pharmaceutical freight without a dedicated GDP-compliant process built specifically for the regulation’s requirements, RoadFreightCompany can assess where the current chain of custody and documentation would hold up against a formal audit and where it would not.